HDAC inhibitors decreased the release of NETs and significantly reduced the levels of pro-inflammatory cytokines in this murine sepsis-induced lung injury model, making HDAC inhibitors a candidate for treatment. The gene discussed is HDAC9; the disease is Sepsis.